| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Sto2g2029 | ATGGGTTTCTTTTCTCAACTATCCCTTCCTTTTGCTTTTTATATcattcttttcctttcctcCCATTGCCTTCTTCTTCATGTCTCAACATCATCAACCACTCTAAGTATCACCACTGACACAGAAGCTTTGATCTCATTCAAGTCTCAATTGAGCAATGATCCTCCTCACCACCACCCATCATTATCTTCTTGGATCCAtaattcatcatcatcaccttgCAATTGGACTGGTGTAGTGTGCAACAATCTTGGCCAAAGAGTGATTGGCTTAAACCTTTCAGGCTTGAGACTCTCAGGTCAGCTAAGTCCTCACATAGGTAACCTCTCTTTTCTTGAGTCTCTCCAATTGCAAAATAACCAATTCACAGGAGTGATTCCTGAGCAAATTGGCAATCTTGGTCGGTTGAGAACTCTAAACATGAGTTTTAATAGACTAGAAGGAACGATTCCTCCGAACATCACTCGCTTAGCCGAACTCGTCGCGCTCGACTTGTCGTCCAACGAGATTGTCGGCCGAATTCCTCGAGATATTGGCACCTTCACAAAGCTTCAAGTCTTGAAATTGGGAAGCAATAACTTGTATGGTACAATACCACCAGGTTTAGGCAATATTTCATCTCTCACAAATATTAGTTTTGGCACAAACACTCTAAGTGGTGGGATTCCAAGTGAACTTGGTAGGCTTAAGAATCTAATTGAGCTTGATCTCATTATTAACAATCTCAATGGAATTGTTCCTCCTTCTATATATAACTTATCTTCCCTAGTTAACTTTGCTATAGCTTCCAACAATTTGTGGGGTGAGATTCCTAAGGATATTGGTCAAAAACTTCCAAAACTCATAATTTTCAATATTTGTTTTAACAAATTCAGAGGTAAAATTCCTGAGTCATTGCATAATATCACCAATATTCAAATCATTCGCATGGCTTACAATCTTTTAGAAGGATCAGTGCCATTAGGTCTTGGAAATCTCCCATTCCTTCATATGTATAATATTGGCTATAACAAGATAGATGTCTCAGAAGGTAGAGGCCTAGACTTCATTATTACTTCTTTGACAAATAGTACCCTCTTGAACTATCTTGCAATTGATGGCAATAGATTGGAAGGTGTGATCCCTGAGACCATTGGAAATCTCTCCAAGGTCCTCTCAAAATTGTACATGGGAGAGAATCATTTCCATGGAAACATACCCACATCGCTTGGAAATCTTAGTGGTTTGAGCTTATTAAACTTGAGTCACAATGATATCTCTGGGGAAATTCCTTTTGAGTTAAGCCAATTAGAGGGATTACAAGAGTTAAGCCTGGATGGAAATAAGATATCAGGAAGTATTCCAAACTCCCTAGGTAGTGGCCTCCAAAGATTAAATCATCTTGATTTGTCAAGCAATGAGCTTGTGGGTGAAATACCTTCTAGTTTTGGGAATTTTCAAAACCTTGTCTTCATGGACATATCTAACAATAAGCTCAATGGAAGCATACCTAGAGAAGTACTCAATCTACCAACTCTAAGTAATGTTTTGAATGTGTCTAAGAACCGTTTAAGTGGGTCTTTGCCTGAAAAAGTAGGGAGTTTGATTGGAGTTTCTACCTTAGATTTCTCTGACAACCTTTTATCTGGCGAAATACCTGCCTCAATAAGCAATTGTCTGAGCCTTGAAAATCTATTTTTGGCACGGAATTCGCTTTCTGGTTCGATTCCGAAAGAACTTGGGGACATCAAAGGATTGGAAACTCTGGACCTTTCTTCCAACCAACTCTTTGGATCCATTCCTATTGAACTTCAAAATCTAAATGCACTTCAGATATTAAACCTCTCTTATAATGATCTAGAAGGAGCCATTCCTAATGGTGGGGTTTTCCAAAACATCTCAGCACTCCATTTAGAAGGCACTATGAAACTTTGTTTGCTTTCCACATGTGGGACTCAAGAAGGTGGAAGAAAGATGTTCATAATCTATATCATCATTGCTATTGTGATAACATTGATACTATGCTTTACAATTGGCTTCTTGTTGTATGTAAAGAGCAGAAAGACAAGGGTAGCAGCATCATCTGAAATGTTAAAGCCACATCATCCAATGGTCTCTTACGACGAGCTTCGTCGGGCAACCGAGAATTTCGACCAAGAGAATTTACTAGGAACGGGAAGCTTTGGCTCAGTCTATAAAGGTCATCTAAGTCAATGGAATAGTAGTGCTGTTGCAATAAAAGTCTTAGACACTTTAAGAACTGGTTCTTTGAAGAGCTTCTTTGTAGAATGTGAAGTTTTGAAGCATACAAGGCACCGGAATCTAGTCAAGTTGATCACAACATGTTCTAGTATAGACTTCAAGAACAATGAATTTTTGGCTTTGGTTTATGAGTTCCTATGTAATGGCAGCTTGGAGGATTGGATTAAGGGAAAGAGAAGacatggaaatggaagtgggtTAGACCTTGTGGAGAGACTGAATATTGCTATTGATATTGCTTGTGCATTGGATTACTTGCACAATGACAATGAAACTCCTATTGTGCATTGTGACTTGAAGCCTAGCAATATACTTTTGGGTGAAGATATGATTGCAAAGGTGGGAGATTTTGGATTGGCTAGGTTGTTGGTTGAAAGGCCAACTATTGATGAAGTTTCAATAAGCTCCACTCATGTCCTTAGAGGTTCAATTGGTTACATACCACCAGAGTATGGATGGGGAGAAAAGGCATCATTTGCGGGAGATGTATATAGTTTTGGCACTGTATTACTAGAGCTCTTCTCTGGAAAGAGTCCAACAGATGATATCTTTACAGGAGGCTTAAGCCTAACTACATGA | 2820 | 0.3816 | MGFFSQLSLPFAFYIILFLSSHCLLLHVSTSSTTLSITTDTEALISFKSQLSNDPPHHHPSLSSWIHNSSSSPCNWTGVVCNNLGQRVIGLNLSGLRLSGQLSPHIGNLSFLESLQLQNNQFTGVIPEQIGNLGRLRTLNMSFNRLEGTIPPNITRLAELVALDLSSNEIVGRIPRDIGTFTKLQVLKLGSNNLYGTIPPGLGNISSLTNISFGTNTLSGGIPSELGRLKNLIELDLIINNLNGIVPPSIYNLSSLVNFAIASNNLWGEIPKDIGQKLPKLIIFNICFNKFRGKIPESLHNITNIQIIRMAYNLLEGSVPLGLGNLPFLHMYNIGYNKIDVSEGRGLDFIITSLTNSTLLNYLAIDGNRLEGVIPETIGNLSKVLSKLYMGENHFHGNIPTSLGNLSGLSLLNLSHNDISGEIPFELSQLEGLQELSLDGNKISGSIPNSLGSGLQRLNHLDLSSNELVGEIPSSFGNFQNLVFMDISNNKLNGSIPREVLNLPTLSNVLNVSKNRLSGSLPEKVGSLIGVSTLDFSDNLLSGEIPASISNCLSLENLFLARNSLSGSIPKELGDIKGLETLDLSSNQLFGSIPIELQNLNALQILNLSYNDLEGAIPNGGVFQNISALHLEGTMKLCLLSTCGTQEGGRKMFIIYIIIAIVITLILCFTIGFLLYVKSRKTRVAASSEMLKPHHPMVSYDELRRATENFDQENLLGTGSFGSVYKGHLSQWNSSAVAIKVLDTLRTGSLKSFFVECEVLKHTRHRNLVKLITTCSSIDFKNNEFLALVYEFLCNGSLEDWIKGKRRHGNGSGLDLVERLNIAIDIACALDYLHNDNETPIVHCDLKPSNILLGEDMIAKVGDFGLARLLVERPTIDEVSISSTHVLRGSIGYIPPEYGWGEKASFAGDVYSFGTVLLELFSGKSPTDDIFTGGLSLTT | 939 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Sto2g2029 | 939 | Pfam | Leucine rich repeat N-terminal domain | 39 | 82 | IPR013210 | - | |
| Sto2g2029 | 939 | ProSitePatterns | Protein kinases ATP-binding region signature. | 716 | 740 | IPR017441 | GO:0005524 | |
| Sto2g2029 | 939 | Gene3D | Ribonuclease Inhibitor | 38 | 195 | IPR032675 | - | |
| Sto2g2029 | 939 | PANTHER | PROTEIN KINASE, PLANT-TYPE, PUTATIVE-RELATED | 26 | 938 | - | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 133 | 157 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 479 | 503 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 455 | 478 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 600 | 625 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 109 | 132 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 430 | 454 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 576 | 599 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 181 | 205 | IPR003591 | - | |
| Sto2g2029 | 939 | SMART | LRR_typ_2 | 229 | 253 | IPR003591 | - | |
| Sto2g2029 | 939 | SUPERFAMILY | Protein kinase-like (PK-like) | 691 | 930 | IPR011009 | - | |
| Sto2g2029 | 939 | Pfam | Leucine rich repeat | 432 | 492 | IPR001611 | GO:0005515 | |
| Sto2g2029 | 939 | Pfam | Leucine rich repeat | 112 | 170 | IPR001611 | GO:0005515 | |
| Sto2g2029 | 939 | PANTHER | OS04G0122200 PROTEIN | 26 | 938 | - | - | |
| Sto2g2029 | 939 | SUPERFAMILY | L domain-like | 39 | 339 | - | - | |
| Sto2g2029 | 939 | Gene3D | Phosphorylase Kinase; domain 1 | 691 | 792 | - | - | |
| Sto2g2029 | 939 | Gene3D | Ribonuclease Inhibitor | 196 | 347 | IPR032675 | - | |
| Sto2g2029 | 939 | ProSiteProfiles | Protein kinase domain profile. | 710 | 939 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Sto2g2029 | 939 | SUPERFAMILY | L domain-like | 384 | 640 | - | - | |
| Sto2g2029 | 939 | Gene3D | Transferase(Phosphotransferase) domain 1 | 793 | 938 | - | - | |
| Sto2g2029 | 939 | Pfam | Protein tyrosine and serine/threonine kinase | 713 | 930 | IPR001245 | GO:0004672|GO:0006468 | |
| Sto2g2029 | 939 | Pfam | Leucine Rich Repeat | 579 | 600 | IPR001611 | GO:0005515 | |
| Sto2g2029 | 939 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 841 | 853 | IPR008271 | GO:0004672|GO:0006468 | |
| Sto2g2029 | 939 | SMART | serkin_6 | 710 | 938 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Sto2g2029 | 939 | Gene3D | Ribonuclease Inhibitor | 348 | 646 | IPR032675 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Sto2g2029 | Sto-Chr2 | 34070845 | 34074321 | Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Sto2g2029 | 6 | 937 | Receptor kinase-like Gene Family | AT5G20480 | 41.614 | 0.0 | 662 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-XII-1 | Sto2g2029 | PK_Tyr_Ser-Thr | 5.4e-38 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Sto2g2029 | - | - | gmx:100783512 | 1241.87 |